Enovis (ENOV) Income from Continuing Operations (2010 - 2026)

Enovis' (ENOV) quarterly Income from Continuing Operations came in at 8411000.0 in Q2 2026, up 84.87% year-on-year from 4549760.87 in Q2 2025, and up 98.38% on a QoQ basis from 518803000.0 in Q4 2025.

Enovis (ENOV) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Enovis (ENOV) has 17 years of Income from Continuing Operations data on file, last reported at 8411000.0 in Q2 2026.

  • On a quarterly basis, Income from Continuing Operations rose 84.87% year-over-year to 8411000.0 in Q2 2026; TTM through Apr 2026 was 1134542000.0, a 39.87% decrease from a year earlier, with the FY2025 full-year figure at 1181711000.0, down 42.82% from the prior year.
  • Income from Continuing Operations for Q2 2026 stood at 8411000.0, up from 518803000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for ENOV reached as high as 120651000.0 in Q3 2022 and fell as low as 703626000.0 in Q4 2024.
  • Historically, Income from Continuing Operations has averaged 124095000.0 across 5 years, with a median of 36455000.0 in 2025.
  • Across the five-year window, Income from Continuing Operations soared 386.58% in 2022 and sank 23034.35% in 2024, its largest moves.
  • Year by year, Income from Continuing Operations stood at 54840000.0 in 2022, then surged by 105.59% to 3068000.0 in 2023, then sank by 23034.35% to 703626000.0 in 2024, then gained by 26.27% to 518803000.0 in 2025, then jumped by 98.38% to 8411000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 8411000.0 in Q2 2026, 518803000.0 in Q4 2025, and 570873000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Enovis 1.50 Bn 1.47 Bn 365.49 Mn -8.41 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 -8.41 Mn
Dec 31, 2025 -518.80 Mn
Oct 3, 2025 -570.87 Mn
Jul 4, 2025 -36.46 Mn
Apr 4, 2025 -55.58 Mn
Dec 31, 2024 -703.63 Mn
Sep 27, 2024 -33.51 Mn
Jun 28, 2024 -18.44 Mn
Mar 29, 2024 -71.84 Mn
Dec 31, 2023 3.07 Mn
Sep 29, 2023 -19.45 Mn
Jun 30, 2023 -14.61 Mn
Mar 31, 2023 -22.85 Mn
Dec 31, 2022 -54.84 Mn
Sep 30, 2022 -65.95 Mn
Jul 1, 2022 120.65 Mn
Apr 1, 2022 -38.10 Mn
Dec 31, 2021 -14.70 Mn
Oct 1, 2021 -13.55 Mn
Jul 2, 2021 -42.10 Mn